Date of Award

Spring 5-2-2025

Document Type

Thesis

Degree Name

Master of Arts (MA)

Department

Economics

First Advisor

Partha Deb

Second Advisor

Karna Basu

Academic Program Adviser

Kenneth McLaughlin

Abstract

The author examines how exposure to the Medicare Part D coverage gap affects future prescription drug use and whether the closure of the gap under the Affordable Care Act (ACA) altered beneficiary behavior. Using 2007–2019 MEPS data, the analysis compares Part D enrollees to similarly aged, privately insured individuals, producing first-differences and difference-in-differences estimates. Before the ACA, exposure to the gap was associated with 4.9 fewer prescription fills relative to comparable non-Part D individuals. After the ACA, the effect fell to a reduction of 2.2 generic fills, with no significant decline in branded use. Sudden out-of-pocket cost increases prompted sharp reductions in utilization, particularly for brand-name drugs. The ACA’s phased discounts attenuated this response. Difference-in-differences estimates confirm that, although the ACA reduced out-of-pocket costs, it did not significantly increase prescription utilization. The findings underscore the importance of cost structure design in health insurance and highlight drawbacks of nonlinear cost-sharing.

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.